Wolverine Trading, LLC Seres Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.48 $22,400 - $47,360	32,000 New	32,000 $30,000
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $10,950 - $22,776	14,600 New	14,600 $11,000
Q2 2023 Aug 23, 2023	BUY	$4.67 - $6.55 $52,771 - $74,015	11,300 New	11,300 $54,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $44,772 - $185,320	-8,200 Reduced 41.41%	11,600 $79,000
Q2 2021 Aug 06, 2021	BUY	$18.46 - $24.36 $180,908 - $238,728	9,800 Added 98.0%	19,800 $473,000
Q1 2021 May 14, 2021	SELL	$17.66 - $28.92 $65,342 - $107,004	-3,700 Reduced 27.01%	10,000 $194,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $25,575 - $41,503	1,100 Added 8.73%	13,700 $360,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $47,124 - $362,124	12,600 New	12,600 $362,000
Q1 2019 May 15, 2019	SELL	$4.83 - $7.21 $64,239 - $95,893	-13,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $60,115 - $118,104	13,300 New	13,300 $64,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $109M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.